Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 58.04%-1.62M | 56.36%-779K | -296.18%-616K | -10,050.00%-1.62M | 159.05%1.4M | 46.39%-3.86M | -1.79M | 135.40%314K | -100.20%-16K | -2.37M |
| Net profit before non-cash adjustment | 107.94%793K | 95.09%-540K | 318.26%1.44M | -61.95%129K | -176.36%-239K | 63.18%-9.99M | ---10.99M | 106.72%345K | 123.40%339K | --313K |
| Total adjustment of non-cash items | -81.74%2.16M | -92.48%791K | -0.68%436K | 19.91%512K | -7.21%425K | -54.39%11.85M | --10.53M | -90.96%439K | -73.72%427K | --458K |
| -Depreciation and amortization | 13.13%1.94M | 64.13%691K | -0.71%417K | -0.72%414K | -8.57%416K | -33.04%1.71M | --421K | -15.49%420K | -16.93%417K | --455K |
| -Reversal of impairment losses recognized in profit and loss | --0 | ---- | ---- | ---- | ---- | -45.11%10.09M | ---- | ---- | ---- | ---- |
| -Disposal profit | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Net exchange gains and losses | 240.91%31K | 20.00%-4K | -214.29%-22K | 5,500.00%56K | 109.09%1K | 13.72%-22K | ---5K | 22.22%-7K | 108.33%1K | ---11K |
| -Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Other non-cash items | 191.04%195K | 477.78%104K | 57.69%41K | 366.67%42K | -42.86%8K | -57.60%67K | --18K | 0.00%26K | -81.63%9K | --14K |
| Changes in working capital | 19.94%-4.58M | 22.09%-1.03M | -430.85%-2.5M | -189.64%-2.27M | 138.64%1.21M | 5.45%-5.72M | ---1.32M | 23.45%-470K | -110.14%-782K | ---3.14M |
| -Change in receivables | 54.91%-3.46M | 74.80%-416K | -2,128.57%-2.03M | 14.74%-1.89M | 123.72%879K | -49.19%-7.67M | ---1.65M | -555.00%-91K | -128.00%-2.22M | ---3.71M |
| -Change in inventory | -861.57%-1.65M | -131.09%-684K | 239.67%1.67M | -536.99%-957K | -65.97%-1.67M | 197.06%216K | --2.2M | -60.19%-1.2M | 149.89%219K | ---1.01M |
| -Change in payables | -69.71%525K | 103.74%70K | -361.76%-2.14M | -52.10%583K | 27.82%2.01M | 352.89%1.73M | ---1.87M | 628.57%816K | 436.12%1.22M | --1.57M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -29.32%-472K | -84.78%-170K | -8.00%-108K | -32.94%-113K | 7.95%-81K | 22.43%-365K | -92K | -11.11%-100K | 16.67%-85K | -88K |
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | -125.49%-115K | 95.70%-4K | 69.86%-22K | -120.00%-30K | -68.57%-59K | 80.93%-51K | -93K | -1.39%-73K | 516.67%150K | -35K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 48.39%-2.21M | 51.62%-953K | -629.08%-746K | -3,706.12%-1.77M | 150.52%1.26M | 46.14%-4.27M | ---1.97M | 113.44%141K | -99.37%49K | ---2.49M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -111.98%-814K | -384.21%-184K | -197.63%-503K | 77.45%-23K | -38.67%-104K | 92.02%-384K | ---38K | 66.27%-169K | 97.20%-102K | ---75K |
| Net investment product transactions | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Interest received (cash flow from investment activities) | -7.05%277K | -10.81%66K | -9.46%67K | -6.58%71K | -1.35%73K | -4.64%298K | --74K | 15.63%74K | 43.40%76K | --74K |
| Investing cash flow | -524.42%-537K | -427.78%-118K | -358.95%-436K | 284.62%48K | -3,000.00%-31K | 98.99%-86K | --36K | 78.26%-95K | 99.78%-26K | ---1K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -35.15%1.18M | 200.62%163K | -80.64%363K | 228.45%1.5M | -142.41%-846K | 1,030.46%1.82M | ---162K | 891.14%1.88M | -80.59%457K | ---349K |
| Net common stock issuance | --1.64M | --701K | --0 | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Increase or decrease of lease financing | -39.95%-522K | -92.63%-183K | -55.32%-146K | -4.30%-97K | -5.49%-96K | 15.36%-373K | ---95K | -6.82%-94K | -6.90%-93K | ---91K |
| Net other fund-raising expenses | 6.76%-276K | 12.16%-65K | 9.46%-67K | 5.33%-71K | 0.00%-73K | -128.14%-296K | ---74K | -15.63%-74K | -41.51%-75K | ---73K |
| Financing cash flow | 75.35%2.02M | 286.10%616K | -91.21%150K | 685.12%2.27M | -97.86%-1.02M | -92.07%1.15M | ---331K | 538.82%1.71M | -94.64%289K | ---513K |
| Net cash flow | ||||||||||
| Beginning cash position | -193.95%-1.55M | -356.26%-1.82M | 24.18%-790K | 1.03%-1.34M | -193.95%-1.55M | -54.25%1.65M | --711K | 21.83%-1.04M | 50.46%-1.35M | --1.65M |
| Current changes in cash | 77.46%-723K | 79.91%-455K | -158.87%-1.03M | 76.28%550K | 107.11%214K | -63.54%-3.21M | ---2.27M | 193.49%1.75M | -77.71%312K | ---3.01M |
| End cash Position | -46.53%-2.28M | -46.53%-2.28M | -356.26%-1.82M | 24.18%-790K | 1.03%-1.34M | -193.97%-1.55M | ---1.55M | 122.16%711K | 21.83%-1.04M | ---1.35M |
| Free cash flow | 35.17%-3.02M | 43.38%-1.14M | -4,360.71%-1.25M | -3,277.36%-1.79M | 145.00%1.16M | 63.47%-4.66M | ---2.01M | 98.19%-28K | -101.29%-53K | ---2.57M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.